Efficacy and safety of spinosad and permethrin creme rinses for pediculosis capitis (head lice)

Pediatrics

Volumn 124, Issue 3, 2009, Pages

  Stough, Dow ^a   Shellabarger, Susan ^b   Quiring, John ^c   Gabrielsen Jr , Alvin A ^d  

^a Burke Pharmaceutical Research   (United States)

^b Anson Group   (United States)

^c QST Consultations Ltd   (United States)

^d Wee Care Pediatrics   (United States)

Author keywords

Ectoparasites; Head lice; Permethrin; Spinosad

Indexed keywords

INSECTICIDE; NATROVA; PERMETHRIN; SPINOSAD; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; APPLICATION SITE ERYTHEMA; APPLICATION SITE IRRITATION; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EYE DISEASE; EYE HYPEREMIA; EYE IRRITATION; FEMALE; HUMAN; HYPEREMIA; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PEDICULOSIS CAPITIS; PHASE 3 CLINICAL TRIAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCALP; SCHOOL CHILD; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DRUG COMBINATIONS; FEMALE; HUMANS; INFANT; INSECTICIDES; LICE INFESTATIONS; MACROLIDES; MALE; MIDDLE AGED; PERMETHRIN; SCALP DERMATOSES; SINGLE-BLIND METHOD; YOUNG ADULT;

EID: 70349233044     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-3762     Document Type: Article

References (17)

1. Centers for Disease Control and Prevention. CDC factsheet. Available at: www.cdc.gov/lice/head/factsheet.html. Accessed August 22, 2008
2. Lebwohl M, Clark L, Levitt J. Therapy for head lice based on life cycle, resistance and safety considerations. Pediatrics. 2007;119(5):965-974 (Pubitemid 46715669)
3. Frankowski BL, Weiner LB; American Academy of Pediatrics, Committee on School Health, Committee on Infectious Diseases. Head lice. Pediatrics. 2002;110(3):638-643
4. Hansen RC. Guidelines for the treatment of resistant pediculosis. Contemp Pediatr. 2000;(suppl): 4-10
5. Pollack RJ, Kiszewski A, Armstrong P, et al. Differential permethrin susceptibility of head lice sampled in the United States and Borneo. Arch Pediatr Adolesc Med. 1999;153(9):969-973 (Pubitemid 29416572)
6. Lee SH, Yoon KS, Williamson MS, et al. Molecular analysis of kdr-like resistance in permethrin-resistant strains of head lice, pediculus capitis. Pestic Biochem Physiol. 2000;66(2):130-143
7. Meinking TL, Serrano L, Hard B, et al. Comparative in vitro pediculicidal efficacy of treatments in a resistant head lice population in the United States. Arch Dermatol. 2002;138(2):220-224 (Pubitemid 34160397)
8. Anon. Drugs for head lice. Med Lett. 1997;39(992):6-7
9. Salgado VL. Studies on the mode of action of spinosad: insect symptoms and physiological correlates. Pesticide Biochem Physiol. 1998;60(2):91-102
10. Spinosad technical bulletin. Available at: www.jlgardencenter.com/ uploads/handouts/Spinosad.pdf. Accessed August 21, 2008
11. Mougabure Cueto G, Zerba E, Inés Picollo M. Embryonic development of human lice: rearing conditions and susceptibility to spinosad [published correction appears in Mem Inst Oswaldo Cruz. 2006;101(5):following 579]. Mem Inst Oswaldo Cruz. 2006;101(3):257-261
12. ParaPRO, LLC. Data on file, protocol 20-206. Carmel, IN: ParaPRO, LLC.
13. Meinking TL. Clinical update on resistance and treatment of Pediculosis capitis. Am J Manag Care. 2004;10(9 suppl):S264-S268
14. Hipolito RB, Mallorca FG, Zuniga-Macaraig ZO, Apolinario PC, Wheeler-Sherman J. Head lice infestation: single drug versus combination therapy with one percent permethrin and trimethoprim/sulfamethoxazole. Pediatrics. 2001;107(3). Available at: www.pediatrics.org/cgi/content/full/107/3/e30
15. Meinking TL, Clineschmidt CM, Chen C, et al. An observer-blinded study of 1% permethrin creme rinse with and without adjunctive combing in patients with head lice. J Pediatrics. 2002;141(5): 665-670 (Pubitemid 35292765)
16. Meinking TL, Vicaria M, Eyerdam DH, Villar ME, Reyna S, Suarez G. Efficacy of a reduced application time of Ovide lotion (0.5% malathion) compared to Nix creme rinse (1% permethrin) for the treatment of head lice. Pediatr Dermatol. 2004;21(6):670-674 (Pubitemid 39657394)
17. Meinking TL, Vicaria M, Eyerdam DH, Villar ME, Reyna S, Suarez G. A randomized, investigator-blinded, time-ranging study of the comparative efficacy of 0.5% malathion gel versus Ovide lotion (0.5% malathion) or Nix creme rinse (1% permethrin) used as labelled, for the treatment of head lice. Pediatr Dermatol. 2007;24(4):405-411 (Pubitemid 47382827)